NEUROGENE INC (NGNE)
(Delayed Data from NSDQ)
$48.59 USD
+4.18 (9.41%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $48.35 -0.24 (-0.49%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -1.23 |
EPS Last Quarter | -1.09 |
Last EPS Surprise | -6.86% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.47 |
Next Year | -4.31 |
EPS (TTM) | -11.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 0.92M | NA |
# of Estimates | NA | NA | 3 | NA |
High Estimate | NA | NA | 0.93M | NA |
Low Estimate | NA | NA | 0.90M | NA |
Year ago Sales | 0.00M | NA | NA | 0.92M |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.23 | -1.15 | -4.47 | -4.31 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -1.15 | -1.18 | -4.42 | -4.50 |
High Estimate | -1.15 | -1.03 | -4.31 | -3.19 |
Low Estimate | -1.34 | -1.27 | -4.56 | -5.28 |
Year ago EPS | -1.64 | NA | NA | -4.47 |
Year over Year Growth Est. | 25.00% | NA | NA | 3.58% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 4 | 4 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.23 | -1.15 | -4.47 | -4.31 |
7 Days Ago | -1.23 | -1.15 | -4.47 | -4.31 |
30 Days Ago | -1.23 | -1.15 | -4.47 | -4.31 |
60 Days Ago | -1.06 | -0.98 | -4.15 | -4.07 |
90 Days Ago | -1.06 | -0.98 | -4.15 | -4.07 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.23 | -1.15 | -4.47 | -4.31 |
Zacks Consensus Estimate | -1.23 | -1.15 | -4.47 | -4.31 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.09 | -1.00 | NA | -1.64 | NA |
Estimate | -1.02 | -1.03 | NA | -3.20 | NA |
Difference | -0.07 | 0.03 | NA | 1.56 | 0.51 |
Surprise | -6.86% | 2.91% | NA | 48.75% | 14.93% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more